Skip to main content
Premium Trial:

Request an Annual Quote

Perlegen Wins $2.1M NIDA Grant to Study Genetics of Nicotine Addiction

NEW YORK, Nov. 17 (GenomeWeb News) - Perlegen Sciences has received a $2.1 million contract from the US National Institute on Drug Abuse to study genetic variations and candidate genes associated with nicotine addiction, the firm said today.


Scientists at WashingtonUniversity in St. Louis will use Perlegen technology to analyze more than 1.5 million SNPs across the genome in people highly addicted to nicotine. They will compare their findings with those conducted on people who are not addicted to nicotine.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.